Cargando…
Targeted and Enhanced Antimicrobial Inhibition of Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles
[Image: see text] In this work, mesoporous (pore size below 4 nm) composite nanoparticles of ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) of size d ≤ 10 nm (dia.) have been synthesized through the in situ solvochemical reduction method using NaBH(4). These composite nanoparticles exhibited excellent killi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637601/ https://www.ncbi.nlm.nih.gov/pubmed/34869986 http://dx.doi.org/10.1021/acsomega.1c04139 |
_version_ | 1784608775665090560 |
---|---|
author | Pandey, Monica Singh, Monika Wasnik, Kirti Gupta, Shubhra Patra, Sukanya Gupta, Prem Shankar Pareek, Divya Chaitanya, Nyshadham Sai Naga Maity, Somedutta Reddy, Aramati B. M. Tilak, Ragini Paik, Pradip |
author_facet | Pandey, Monica Singh, Monika Wasnik, Kirti Gupta, Shubhra Patra, Sukanya Gupta, Prem Shankar Pareek, Divya Chaitanya, Nyshadham Sai Naga Maity, Somedutta Reddy, Aramati B. M. Tilak, Ragini Paik, Pradip |
author_sort | Pandey, Monica |
collection | PubMed |
description | [Image: see text] In this work, mesoporous (pore size below 4 nm) composite nanoparticles of ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) of size d ≤ 10 nm (dia.) have been synthesized through the in situ solvochemical reduction method using NaBH(4). These composite nanoparticles exhibited excellent killing efficacy against Gram-positive/negative bacterial and fungal strains even at a very low dose of 0.010 μg/mL. Additionally, by applying the in silico docking approach, the nanoparticles and microorganism-specific targeted proteins and their interactions have been identified to explain the best anti-bacterial/anti-fungal activities of these composites. For this purpose, the virulence and resistance causing target proteins such as PqsR, RstA, FosA, and Hsp90 of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Candida albicans have been identified to find out the best inhibitory action mechanisms involved. From the in vitro study, it is revealed that all the composite nanoparticle types used here can act as potent antimicrobial components. All the composite nanoparticles have exhibited excellent inhibition against the microorganisms compared to their constituent single metal or metal oxide nanoparticles. Among the nanoparticle types, the ZnO–Ag(2)O/Ag composite nanoparticles exhibited the best inhibition activity compared to the other reported nanoparticles. The microorganisms which are associated with severe infections lead to the multidrug resistance and have become a huge concern in the healthcare sector. Conventional organic antibiotics are less stable at a higher temperature. Therefore, based on the current demands, this work has been focused on designing inorganic antibiotics which possess stability even under harsh conditions. In this direction, our developed composite nanoparticles were explored for potential uses in the healthcare technology, and they may solve many problems in global emergency and epidemics caused by the microorganisms. |
format | Online Article Text |
id | pubmed-8637601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-86376012021-12-03 Targeted and Enhanced Antimicrobial Inhibition of Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles Pandey, Monica Singh, Monika Wasnik, Kirti Gupta, Shubhra Patra, Sukanya Gupta, Prem Shankar Pareek, Divya Chaitanya, Nyshadham Sai Naga Maity, Somedutta Reddy, Aramati B. M. Tilak, Ragini Paik, Pradip ACS Omega [Image: see text] In this work, mesoporous (pore size below 4 nm) composite nanoparticles of ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) of size d ≤ 10 nm (dia.) have been synthesized through the in situ solvochemical reduction method using NaBH(4). These composite nanoparticles exhibited excellent killing efficacy against Gram-positive/negative bacterial and fungal strains even at a very low dose of 0.010 μg/mL. Additionally, by applying the in silico docking approach, the nanoparticles and microorganism-specific targeted proteins and their interactions have been identified to explain the best anti-bacterial/anti-fungal activities of these composites. For this purpose, the virulence and resistance causing target proteins such as PqsR, RstA, FosA, and Hsp90 of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, and Candida albicans have been identified to find out the best inhibitory action mechanisms involved. From the in vitro study, it is revealed that all the composite nanoparticle types used here can act as potent antimicrobial components. All the composite nanoparticles have exhibited excellent inhibition against the microorganisms compared to their constituent single metal or metal oxide nanoparticles. Among the nanoparticle types, the ZnO–Ag(2)O/Ag composite nanoparticles exhibited the best inhibition activity compared to the other reported nanoparticles. The microorganisms which are associated with severe infections lead to the multidrug resistance and have become a huge concern in the healthcare sector. Conventional organic antibiotics are less stable at a higher temperature. Therefore, based on the current demands, this work has been focused on designing inorganic antibiotics which possess stability even under harsh conditions. In this direction, our developed composite nanoparticles were explored for potential uses in the healthcare technology, and they may solve many problems in global emergency and epidemics caused by the microorganisms. American Chemical Society 2021-11-16 /pmc/articles/PMC8637601/ /pubmed/34869986 http://dx.doi.org/10.1021/acsomega.1c04139 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Pandey, Monica Singh, Monika Wasnik, Kirti Gupta, Shubhra Patra, Sukanya Gupta, Prem Shankar Pareek, Divya Chaitanya, Nyshadham Sai Naga Maity, Somedutta Reddy, Aramati B. M. Tilak, Ragini Paik, Pradip Targeted and Enhanced Antimicrobial Inhibition of Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles |
title | Targeted and Enhanced Antimicrobial Inhibition of
Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles |
title_full | Targeted and Enhanced Antimicrobial Inhibition of
Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles |
title_fullStr | Targeted and Enhanced Antimicrobial Inhibition of
Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles |
title_full_unstemmed | Targeted and Enhanced Antimicrobial Inhibition of
Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles |
title_short | Targeted and Enhanced Antimicrobial Inhibition of
Mesoporous ZnO–Ag(2)O/Ag, ZnO–CuO, and ZnO–SnO(2) Composite Nanoparticles |
title_sort | targeted and enhanced antimicrobial inhibition of
mesoporous zno–ag(2)o/ag, zno–cuo, and zno–sno(2) composite nanoparticles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637601/ https://www.ncbi.nlm.nih.gov/pubmed/34869986 http://dx.doi.org/10.1021/acsomega.1c04139 |
work_keys_str_mv | AT pandeymonica targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT singhmonika targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT wasnikkirti targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT guptashubhra targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT patrasukanya targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT guptapremshankar targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT pareekdivya targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT chaitanyanyshadhamsainaga targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT maitysomedutta targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT reddyaramatibm targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT tilakragini targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles AT paikpradip targetedandenhancedantimicrobialinhibitionofmesoporousznoag2oagznocuoandznosno2compositenanoparticles |